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Adiponectin is a protein hormone that can affect major metabolic processes including glucose regulation and
fat metabolism. Our previous genome-wide association (GWA) study of circulating plasma adiponectin levels
in Filipino women from the Cebu Longitudinal Health and Nutrition Survey (CLHNS) detected a 100 kb two-
SNP haplotype at KNG1–ADIPOQ associated with reduced adiponectin (frequency 5 0.050, P 5 1.8 3
10225). Subsequent genotyping of CLHNS young adult offspring detected an uncommon variant [minor
allele frequency (MAF) 5 0.025] located ∼800 kb from ADIPOQ that showed strong association with lower
adiponectin levels (P 5 2.7 3 10215, n 5 1695) and tagged a subset of KNG1–ADIPOQ haplotype carriers
with even lower adiponectin levels. Sequencing of the ADIPOQ-coding region detected variant R221S
(MAF 5 0.015, P 5 2.9 3 10269), which explained 17.1% of the variance in adiponectin levels and largely
accounted for the initial GWA signal in Filipinos. R221S was not present in 12 514 Europeans with previously
sequenced exons. To explore the mechanism of this substitution, we re-measured adiponectin level in 20
R221S offspring carriers and 20 non-carriers using two alternative antibodies and determined that the pres-
ence of R221S resulted in artificially low quantification of adiponectin level using the original immunoassay.
These data provide an example of an uncommon variant responsible for a GWA signal and demonstrate that
genetic associations with phenotypes measured by antibody-based quantification methods can be affected
by uncommon coding SNPs residing in the antibody target region.
INTRODUCTION
Secreted almost exclusively from adipocytes into the blood-
stream, adiponectin is an abundant protein hormone that affects
metabolic processes including glucose regulation and fat metab-
olism (1). Circulating plasma adiponectin level is substantially
heritable (2–4), and low levels are associated with increased
body mass index (BMI) and risk of cardiovascular disease, type
2 diabetes, atherosclerosis and metabolic syndrome (1,5–8).
Understanding the genetic basis of adiponectin level may help
unravel the etiology of these complex diseases.
The gene ADIPOQ, which encodes adiponectin, is an
obvious candidate for influencing adiponectin level and its
effects on target tissues. Candidate gene association studies
(9–12) as well as genome-wide association (GWA) studies
(13–16) of common SNPs [minor allele frequency (MAF) ≥
0.05] have identified several potentially functional ADIPOQ
variants. In vitro studies have shown that rare (MAF ,
0.005) and uncommon (0.005 ≤ MAF , 0.05) missense var-
iants can disrupt the multimerization necessary for adiponectin
secretion (17) and that SNPs in the ADIPOQ promoter may
alter its transcription (18). Nonetheless, the true causal var-
iants responsible for the previously reported GWA signals at
ADIPOQ have not yet been established.
We previously reported a 100 kb two-SNP haplotype span-
ning the KNG1–ADIPOQ gene region that is associated with
reduced adiponectin level in 1776 Filipino women from the
Cebu Longitudinal Health and Nutrition Survey (CLHNS)
∗To whom correspondence should be addressed at: Department of Genetics, University of North Carolina at Chapel Hill, 120 Mason Farm Road,
Chapel Hill, NC 27599-7264, USA. Tel: +1 9199662913; Fax: +1 9198430291; Email: mohlke@med.unc.edu
# The Author 2011. Published by Oxford University Press. All rights reserved.
For Permissions, please email: journals.permissions@oup.com
Human Molecular Genetics, 2012, Vol. 21, No. 2 463–471
doi:10.1093/hmg/ddr480
Advance Access published on October 18, 2011
(19). Compared with the strongest single SNP associated with
adiponectin in the GWA study (rs864265, MAF ¼ 0.124,
b ¼ 20.123, P ¼ 3.8 × 1029), the C-T rs11924390-
rs864265 haplotype showed substantially stronger evidence
of association with a larger effect size (frequency ¼ 0.050,
b ¼ 20.385, P ¼ 1.8 × 10225). Imputation of SNPs from
the 1000 Genomes Pilot Project (June 2010) failed to identify
any single SNP with association evidence at this level of sig-
nificance, suggesting either that the true causal variant was
poorly imputed, thus weakening its evidence of association,
or that a lower frequency variant or more than one variant
may be responsible for the GWA signal (19).
In the current study, we further characterized this KNG1–
ADIPOQ haplotype association by identifying an uncommon
missense variant responsible for much of the signal. In
young adult offspring from the CLHNS, in whom the
haplotype showed a similar effect (frequency ¼ 0.052,
b ¼ 20.386, P ¼ 8.7 × 10232) (19), the observation of an
additional putative association signal in the region led
serendipitously, although indirectly, to an explanation for the
original GWA signal at KNG1–ADIPOQ.
RESULTS
To study the genetic basis of circulating plasma adiponectin
level and other metabolic traits, we genotyped using the Meta-
boChip a set of young adult offspring from the CLHNS. The
offspring did not show evidence of population substructure
(Supplementary Material, Fig. S1), and an assessment of
global ancestry showed them clustering with other Asian indi-
viduals as expected (Supplementary Material, Fig. S2). Of
140 696 polymorphic MetaboChip SNPs tested for association
with natural log-transformed adiponectin level in 1695 off-
spring, the two most strongly associated SNPs (P , 5.0 ×
1028) were located 800 kb apart on chromosome 3
(Fig. 1). Located upstream of the ADIPOQ gene, the first
SNP, rs864265 (P ¼ 1.0 × 10213, Table 1), had been detected
by our previous GWA study (19). The second SNP,
rs117016164, showed stronger evidence of association (P ¼
2.7 × 10215, Table 1), and is located downstream of the
ETV5 gene. Originally identified by the 1000 Genomes
Project as a singleton in a CHB HapMap sample
(NA18593), rs117016164 had not been detected in CEU,
JPT or YRI samples. This SNP was uncommon in the
CLHNS offspring (MAF ¼ 0.025), and exhibited very low
linkage disequilibrium (LD) with all other SNPs within the
densely typed ETV5 gene region (r2 , 0.1, chr3:187.2–
187.4 Mb in Fig. 1). These data suggested a possible second
and novel association signal 800 kb away from the original
GWA signal.
To validate the evidence of association of rs117016164 with
adiponectin in the CLHNS offspring, we re-genotyped the
SNP and, observing concordant genotypes, then performed a
permutation test, which generated strong and consistent evi-
dence of association (Pperm , 10
29). In addition, the 1764
CLHNS mothers showed directionally consistent association
(P ¼ 3.2 × 1027, Table 1). Using a general linear mixed
model accounting for sample relatedness, the combined set
of offspring and mothers strengthened the evidence of
association of rs117016164 with adiponectin levels
(Pcombined ¼ 7.0 × 10217).
We next examined the relationship between rs117016164
and the two SNPs from the previously identified adiponec-
tin-associated KNG1–ADIPOQ haplotype (rs119243940 and
rs864265). The SNP rs117016164 was in low LD with both
rs119243940 (D′ ¼ 0.38, r2 ¼ 0.004) and rs864265 (D′ ¼
0.37, r2 ¼ 0.024). Carrying the C-T haplotype at KNG1–
ADIPOQ was associated with lower adiponectin levels in
CLHNS offspring (P ¼ 1.0 × 10237, Fig. 2A). When
rs117016164 was included to form three-SNP haplotypes, all
carriers of the original two-SNP C-T haplotype still had
significantly lower adiponectin levels than non-carriers; they
carried haplotype H4 (C-C-T, P ¼ 2.9 × 10216) and/or haplo-
type H6 (T-C-T, P ¼ 2.1 × 10239) (Table 2). A post hoc com-
parison of these two haplotypes showed that their strengths of
association were significantly different (P ¼ 2.9 × 10218),
suggesting that the minor allele (T) of rs117016164 tagged a
subset of KNG1-ADIPOQ haplotype carriers with even
lower adiponectin levels. A consistent pattern of strong
haplotype association was also observed in the mothers
(Supplementary Material, Table S1). These data suggested
that the H4 and H6 haplotypes together likely harbored two
or more SNPs that might account for the observed evidence
of association at the KNG1–ADIPOQ locus.
Three pieces of evidence led us to hypothesize that coding
variants in ADIPOQ could explain the observed haplotype
associations. First, although ETV5 was a plausible candidate
gene based on a nearby SNP previously reported to be
associated with BMI (20) and the inverse relationship
between adiponectin level and BMI, rs117016164 was not
located in a conserved region or a regulatory element pre-
dicted based on chromatin state. Second, the evidence of
Figure 1. Two adiponectin association signals (P , 5.0 × 1028) on chromo-
some 3 in 1695 CLHNS offspring. Regional plot of MetaboChip SNP associa-
tions with plasma adiponectin level on chromosome 3 (187.2–188.2 Mb). The
previously associated 100 kb two-SNP KNG1–ADIPOQ haplotype of
rs119243940 and rs864265 spans the region shaded gray. Plot was generated
using LocusZoom (45).
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long haplotypes linking rs117016164 to the two adiponectin-
associated SNPs in the KNG1-ADIPOQ region reinforced
the possibility that causal variants could be located in other
genes in the region; among these, ADIPOQ was the strongest
biological candidate. Third, although decreased gene expres-
sion by a non-coding regulatory variant is a more likely scen-
ario at many GWA loci, amino acid substitutions in ADIPOQ
have been shown to disrupt the multimerization of the adipo-
nectin protein necessary for its secretion into the bloodstream
(17). We hypothesized then that one or more low-frequency-
coding variants in ADIPOQ could have large effects on
adiponectin levels consistent with the observed associations.
To identify rare or uncommon coding variants in ADIPOQ,
we sequenced the translated exons of the gene in 47 CLHNS
offspring, a sample set enriched for carriers of the H6 and
H4 haplotypes. We observed three variants in the coding
region, each in at least one sample: G15G (rs2241766), a
common variant that previously showed modest association
with adiponectin in the CLHNS mothers (P ¼ 0.0077) (19);
G48D, a novel missense variant in one individual with
average adiponectin level (2.15 mg/ml); and R221S, a mis-
sense variant first reported in Japanese (21). To help predict
their potential impact on protein structure and function, we
performed bioinformatic annotation of the two observed mis-
sense variants. G48D was predicted by polymorphism pheno-
typing (PolyPhen) to be ‘likely damaging’ with a score of
0.997 and by sorting intolerant from tolerant (SIFT) to
‘affect protein function’ with a score of 0.00. R221S was pre-
dicted by PolyPhen to be ‘likely benign’ with a score of 0.000
and by SIFT to be ‘tolerated’ with a score of 0.41. The differ-
ence in the predicted effects of the two variants reflects that
ADIPOQ amino acid 48 is more highly conserved across
related protein sequences, and therefore more sensitive to sub-
stitution by an unlike residue. Eight other previously reported
missense variants (9,10,21–24) were not found in these 47 off-
spring samples, including G45R, G84R, G90S, R92X, Y111H,
R112C, I164T and H241P. However, as the I164T substitution
was uncommon (MAF ¼ 0.009) and strongly associated with
lower adiponectin in Japanese (12), we included this SNP in
follow-up genotyping.
Figure 2. Association of KNG1–ADIPOQ haplotype in CLHNS offspring is attenuated by ADIPOQ missense variant R221S. Adiponectin residuals plotted by
number of copies of (A) the associated C-T KNG1–ADIPOQ haplotype, (B) the ADIPOQ missense variant R221S and (C) the KNG1–ADIPOQ haplotype when
conditioned on R221S.
Table 1. Association of three SNPs with plasma adiponectin level in CLHNS offspring and mothers
SNP (gene) Allele 1/2 CLHNS offspring (n ¼ 1695) CLHNS mothers (n ¼ 1764) Combined samples
MAF b (SE) P-values R2 MAF b (SE) P-values R2 b (SE) P-values
rs864265 (ADIPOQ) T/G 0.129 20.134 (0.018) 1.0 × 10213 0.032 0.124 20.124 (0.020) 4.8 × 10210 0.022 20.128 (0.014) 4.2 × 10220
rs117016164 (ETV5) T/C 0.025 20.304 (0.038) 2.7 × 10215 0.036 0.030 20.198 (0.039) 3.2 × 1027 0.015 20.240 (0.028) 7.0 × 10217
R221S (ADIPOQ) A/C 0.015 20.853 (0.046) 2.9 × 10269 0.171 0.015 20.811 (0.051) 2.0 × 10253 0.132 20.823 (0.035) 4.3 × 10299
Effect betas (b), standard errors (SE), P-values and squared type-II partial correlations (R2) are reported in terms of the minor allele (underlined) and for natural
log-transformed values of adiponectin. MAFs are reported for all 1774 unrelated offspring and 1798 mothers, regardless of covariate completeness. In the analyses
of offspring, models were adjusted for sex and BMI. In the analyses of mothers, models were adjusted for age, age2, household assets, natural log-transformed
income, menopausal status and BMI. In the combined analyses, models accounting for sample relatedness were adjusted for sex, age, age2, household assets,
natural log-transformed income and BMI. All covariates were from the 2005 survey.
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We directly genotyped three candidate coding variants
(G48D, I164T and R221S) in the complete sets of offspring
and mothers, and tested each for association with plasma adi-
ponectin level. No additional G48D carriers were identified,
and I164T was monomorphic in both the mothers and off-
spring. In contrast, R221S was present in the offspring with
MAF ¼ 0.015, and carriers had significantly lower adiponectin
levels than non-carriers (P ¼ 2.9 × 10269) (Fig. 2B, Table 1).
The ADIPOQ R221S variant was in low LD with the ETV5
variant (rs117016164) (D′ ¼ 0.54, r2 ¼ 0.17). We observed
similar evidence of R221S association in the mothers (P ¼
2.0 × 10253) (Supplementary Material, Fig. S3, Table S1),
and in the combined mothers and offspring (Pcombined ¼
4.3 × 10299) (Table 1). R221S explained 17.1 and 13.2% of
phenotypic variation in the offspring and mothers, respective-
ly. Thus, only one of the three observed non-synonymous
amino acid substitution variants in ADIPOQ (R221S) was
strongly associated with adiponectin in Filipinos.
To determine the relationship between the uncommon coding
variant R221S and the associated haplotypes, we performed
conditional analyses. Conditioning on R221S, offspring carriers
of the two-SNP C-T KNG1–ADIPOQ haplotype still had sig-
nificantly lower adiponectin levels, but the association was sub-
stantially attenuated (P ¼ 5.6 × 10210, Fig. 2C). Carriers of the
three-SNP H6 haplotype showed greatly attenuated association
(P ¼ 0.030), whereas carriers of H4 were still significantly asso-
ciated with lower adiponectin levels (P ¼ 1.3 × 1028). The
mothers showed similar attenuations (Supplementary Material,
Fig. S3C and data not shown). We also re-phased haplotypes in
the mothers after including the R221S variant and found that it
segregated very infrequently (at most twice) on any haplotypes
other than H4 and H6. These results suggested not only that the
H6 haplotype association was largely explained by R221S, but
also that one or more additional adiponectin-associated variants
remained to be identified on the H4 haplotype, as its association
was only partially explained by R221S.
In the CLHNS samples, adiponectin level shows modest but
significant negative correlation (P , 0.0001) with multiple
metabolic traits, including BMI, waist circumference, fasting
glucose and insulin and homeostasis model assessment
indices of insulin sensitivity and beta cell function (19). We
tested R221S in both the mothers and offspring for association
with these traits and lipid profiles and did not observe signifi-
cant evidence of association (P ¼ 0.13–0.95 in offspring and
P ¼ 0.20–0.98 in mothers, data not shown). In comparison,
the ADIPOQ SNP rs864265 from the original GWA signal
had shown nominal association (P , 0.05) in the offspring
with several of these traits (19). With the comparatively
smaller MAF of R221S, our study had ,10% power to
detect such associations with comparable effect sizes at P ,
0.05. Given prior in vitro biochemical evidence that R221S
does not affect adiponectin multimer formation or secretion
(17), we hypothesized that the R221S substitution affected
the original antibody detection of adiponectin, resulting in ar-
tificially low levels among carriers. The original enzyme-
linked immunosorbent assay (ELISA) consisted of two mono-
clonal antibodies targeting amino acids 104–244 of ADIPOQ.
We re-measured plasma adiponectin level in 20 R221S car-
riers and 20 sex- and BMI-matched non-carriers using two al-
ternative polyclonal antibodies that recognize epitopes within
amino acids 17–27 and 56–70, neither of which should be
affected by amino acid 221. Adiponectin measurements were
not consistent between the original ELISA and each of the al-
ternative antibodies (Fig. 3 and data not shown). The subset of
R221S carriers had lower adiponectin levels than non-carriers
based on the original ELISA, but carriers and non-carriers
showed similar distributions with the alternative antibodies.
These results suggested that R221S changed the structure of
adiponectin enough to alter the binding affinity of the mono-
clonal antibody in the original ELISA. These results confirmed
that the very strong statistical association of R221S with lower
adiponectin level was likely due to a methodological artifact
of antibody specificity.
We then re-evaluated the evidence of adiponectin associ-
ation after conditioning on R221S. Overall, there were no sub-
stantial changes in any SNP associations at loci other than
KNG1–ADIPOQ in the offspring (data not shown) or
mothers (Supplementary Material, Fig. S4), including at
CDH13, a previously reported GWA signal in the CLHNS
(19); similar results were observed after removing R221S car-
riers from analysis (data not shown and Supplementary Mater-
ial, Fig. S4). To examine the associations of additional
variants in the 187.2–188.2 Mb region of chromosome 3, we
re-imputed in the mothers SNPs from the November 2010
release of the 1000 Genomes Project (Supplementary Material,
Fig. S5). Prior to conditioning on R221S, the most significant-
ly associated SNP in the region was rs864265 (P ¼ 2.2 ×
10210). After conditioning, this signal was highly attenuated
Table 2. Association of three-SNP haplotypes with plasma adiponectin level in CLHNS offspring
Haplotype rs117016164 rs11924390 rs864265 Haplotype frequency Number of carriers b SE P-value
H1 C C G 0.435 1196 — — —
H2 C T G 0.421 1166 0.017 0.012 0.15
H3 C T T 0.075 256 0.022 0.022 0.31
H4 C C T 0.044 154 20.237 0.029 2.9 3 10216
H5 T C G 0.010 33 20.060 0.058 0.30
H6 T C T 0.009 31 20.817 0.061 2.1 3 10239
H7 T T G 0.005 19 0.035 0.076 0.64
H8 T T T 0.001 5 20.199 0.164 0.23
Effect betas (b), standard errors (SE) and P-values were calculated for each haplotype relative to the most common reference haplotype. Frequencies are reported
for all 1774 unrelated offspring, regardless of covariate completeness. Significant associations (P , 0.05) are in boldface. Models were adjusted for sex and for
BMI from the 2005 survey. A post hoc comparison of H4 and H6 showed that their strengths of association were significantly different (P ¼ 2.9 3 10218).
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(P ¼ 0.076) and the most significantly associated SNP was
rs58575091 (P ¼ 3.7 × 1025). We re-evaluated eight
ADIPOQ SNPs that were identified as candidate functional
variants in the literature (19), and of those, only rs266729
and rs182052 still showed nominal association (P , 0.05)
after conditioning on R221S (Supplementary Material,
Table S2). These associations remained significant after condi-
tioning on both R221S and copies of the C-T haplotype
(rs266729, P ¼ 1.8 × 1024 and rs182052, P ¼ 4.6 × 1024).
When the two SNPs were included in the model together,
rs266729 was modestly more significant than rs182052 (P ¼
0.067 versus P ¼ 0.22). Comparable results were obtained
when removing R221S carriers from analysis (data not
shown). Thus, after conditioning on R221S, moderate evi-
dence of association with adiponectin level remained. The
conditional analyses suggested that two or more additional
variants still play a role in trait variability in this study.
DISCUSSION
Follow-up of our previous GWA study in the CLHNS demon-
strates that the two-SNP haplotype in the KNG1–ADIPOQ
region associated with lower plasma adiponectin level can
be attributed to a coding variant that affected antibody speci-
ficity. This uncommon non-synonymous amino acid substitu-
tion variant (R221S, MAF ¼ 0.015) was responsible for
most of the initial GWA signal, which was based on a
survey of common variants. R221S explained 17.1 and
13.2% of adiponectin variation in the offspring and mothers,
respectively. In comparison, the index SNP from the original
GWA study (rs864265, MAF ¼ 0.129) explained 3.2 and
2.2% of variation, respectively. We discovered R221S by
detecting in the offspring a long three-SNP haplotype
created by another uncommon SNP nearly 800 kb away
from ADIPOQ. This SNP (rs117016164) was genotyped for-
tuitously, as it was included on the MetaboChip to fine-map
the ETV5 gene region previously associated with BMI (20).
The location of rs117016164 downstream of ETV5 and its
lack of overlap with predicted regulatory elements in a
relevant cell type, such as adipocytes, made ETV5 a less
compelling candidate gene for regulating adiponectin level.
Furthermore, rs117016164 was the only variant in the ETV5
region to show evidence of association comparable with that
of rs864265 near ADIPOQ, suggesting the presence of a
long haplotype spanning the entire region. Prior biochemical
experiments have shown that ADIPOQ amino acid substitu-
tions can disrupt the multimer aggregation required for adipo-
nectin secretion (17). Targeted sequencing of ADIPOQ-coding
regions in carriers of the associated haplotypes then revealed
R221S, which segregated primarily on the two long haplotypes
associated with lower adiponectin level in the entire cohort.
Therefore, the causal variant was not only detectable 800 kb
away, but was also nearly 10 times less frequent and explained
a far greater proportion of phenotypic variance than the GWA
index SNP, in line with a previously proposed association
causation scenario (25). The proportion of reported GWAS
signals explained by uncommon variants remains to be deter-
mined, but R221S is a clear example of one.
Because R221S has been reported previously only in Japa-
nese (21), Korean (26,27) and Japanese–Brazilian (28)
cohorts, the variant may be specific to Asian-ancestry popula-
tions. This R221S variant (CGT to AGT) was also observed to
be monomorphic in 12 514 individuals of European ancestry
with sequenced exons (M.R. Nelson et al., manuscript in prep-
aration). A different ADIPOQ missense variant (I164T) with
low frequency in Japanese (MAF ¼ 0.009) has been shown
to be associated with lower adiponectin levels (12), consistent
with biochemical evidence that the I164T-containing adipo-
nectin does not form trimers or high-molecular-weight multi-
mers and impairs secretion from the adipocyte (17). However,
we did not observe I164T or any other of seven known
missense variants among the CLHNS samples.
The observed data did not support a biological role for
R221S in lowering adiponectin level. Despite explaining
13–17% of variation in adiponectin levels in the CLHNS,
we observed no evidence of association of R221S with meta-
bolic traits or with waist circumference, which is a well-
known predictor of adiponectin levels. This result could
reflect limited power. R221S also did not show any deficiency
in formation of adiponectin trimers, hexamers or
high-molecular-weight multimers in vitro (17), and bioinfor-
matic annotations that suggested R221S would not substantial-
ly alter the protein’s conformation. Among the previous
reports of R221S, adiponectin levels in carriers were signifi-
cantly lower (28), indistinguishable from non-carriers (21),
or not reported due to low MAF (26,27). We hypothesized
that the R221S variant is located on the surface of the
protein at a position that may alter the epitope recognized
by the adiponectin antibody. Two previous reports support
this scenario. The first describes an African-American-specific
K29M amino acid substitution in the soluble circulating
Figure 3. Inconsistent plasma adiponectin measurements between assays are
attributable to R221S. Plots of relative adiponectin levels of 20 R221S non-
carriers (R/R: open circles) are shown compared with 20 R221S carriers
(R/S: filled circles), as measured by two antibody-based assays for ADIPOQ
[left: epitopes within amino acids (a.a.) 104–244, right: 56–70]. Within
each assay, all adiponectin levels are natural log-transformed and zero-
centered on the mean value of R221S non-carriers, and t-test P-values are
reported for the difference in means between carriers and non-carriers.
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intracellular adhesion molecule-1 (sICAM-1) protein that
resulted in the errant measurement of sICAM-1 by an
ELISA using monoclonal antibodies to the region (29). The
second describes a GWA study of European-ancestry
samples in which a V32M substitution in the natriuretic
peptide precursor A gene was strongly associated with
mature plasma atrial natriuretic peptide only if the phenotype
was measured by an immunoassay targeting the N-terminal
epitope (30). Altered trait detection could be responsible for
other associations of non-synonymous ADIPOQ variants
with adiponectin or for any other genetic associations with
protein traits assayed by monoclonal antibodies binding the
region containing the mutation. Of further concern to the
study of complex traits on a genome-wide level is that a
study’s power to detect associations at other loci could be
affected by samples with noisy phenotypes, especially if
they lie in the extreme tails of the distribution.
The novel singleton missense variant (G48D) we identified
in ADIPOQ is located in the conserved glycine repeat motif
region. Other nearby glycine-to-aspartic acid substitutions in
adiponectin (17) and the homologous mannose-binding
protein (31) showed deficiency in the formation of
high-molecular-weight multimers, suggesting that G48D may
also disrupt multimer formation and reduce the stability of
its collagen helix domain. However, as the single CLHNS
G48D carrier had only slightly below average adiponectin
level, the variant may have no effect.
We hypothesize that two or more variants of considerably
smaller effect explain the remaining GWA signal at
ADIPOQ after adjusting for R221S. The true causal variants
in the remaining signal could be the same as those underlying
ADIPOQ signals from GWA studies of European samples
(13–16). The previously described candidate SNP rs266729
previously showed evidence of association in the CLHNS
(19), and has been predicted to alter an SP1 transcription
factor-binding site (32). It is also part of a three-SNP haplo-
type shown to have an in vitro effect on ADIPOQ promoter ac-
tivity and on DNA-binding activity of nuclear proteins (18).
Other putative regulatory regions near ADIPOQ (33–35)
may also be promising targets for additional variants. Ultim-
ately, both more comprehensive sequencing of the ADIPOQ
gene region and improved imputation of SNPs from the
1000 Genomes Project may be needed to systematically
identify additional candidate causal variants, especially of
low frequency.
In summary, we characterized a GWA signal for lower
plasma adiponectin level in a Filipino cohort and showed
that a population-specific uncommon missense variant in the
adiponectin-coding gene resulted in artificially low adiponec-
tin measurements in a subset of samples and thus was largely
responsible for the observed association signal detected with
common variants. Our work highlights how genetic associa-
tions with phenotypes measured by antibody-based quantifica-
tion methods can be affected by uncommon coding SNPs
residing in the antibody target region. We also demonstrated
the value of targeted sequencing for discovering a variant
with potential functional relevance not yet present in public
SNP databases. Although these findings as a whole do not elu-
cidate the biology underlying the genetics of adiponectin level,
they illustrate an unusual combination of association
phenomena that may inform and caution other researchers per-
forming large-scale genetic association analyses.
MATERIALS AND METHODS
Subjects
The CLHNS participants available for this study included
1798 mothers and 1779 male and female young adult offspring
from a 1983–1984 Filipino birth cohort (36). Trained field
staff conducted in-home interviews and collected quantitative
anthropometric measurements, blood samples and comprehen-
sive environmental data (available on-line at http://www.cpc.
unc.edu/projects/cebu/). Outcome and covariate measures
were taken from the 2005 survey. Informed consent was
obtained from all CLHNS subjects, and the study protocol
was approved by the University of North Carolina Institutional
Review Board for the Protection of Human Subjects. Basic de-
scriptive characteristics of the mothers and offspring are sum-
marized in Supplementary Material, Table S3.
Genotyping and imputation
The 1779 CLHNS offspring were genotyped for 196 725 SNPs
on the MetaboChip (Illumina, San Diego, CA, USA), a custom
array of SNPs designed to replicate and fine-map loci asso-
ciated with metabolic traits. Genotyping was performed by
the Mammalian Genotyping Core at the University of North
Carolina at Chapel Hill (UNC-CH) using the protocol recom-
mended by the manufacturer. Individual sample success rates
exceeded 98.6%. Due to poor genotype clustering, 8610 SNPs
were removed from analysis. SNP quality control filtering was
then performed using PLINK v1.07 (37). We removed 1652
SNPs for success rates ≤97%, 126 SNPs for deviation from
Hardy–Weinberg equilibrium (P , 1026), 228 SNPs for Men-
delian inheritance errors (combined ≥3 discrepancies among
79 duplicate pairs and 4 HapMap CEPH trios genotyped on
the MetaboChip), 21 SNPs for ≥3 genotype discrepancies
with available HapMap genotypes for the 4 CEPH trios and
45 397 SNPs that were monomorphic. Five SNPs did not
pass more than one of these filters, so the final set of high-
quality MetaboChip data included 140 696 SNPs.
Using MACH version 1.0 (38), additional genotypes of
SNPs in the 187.2–188.2 Mb region of chromosome 3 from
the November 2010 release (23 November 2010) of the
1000 Genomes Project were imputed in the mothers based
on reference haplotypes from CEU, CHB and JPT samples.
MACH was also used to generate best-guess phased haplo-
types (those with highest posterior probabilities) of 351 direct-
ly genotyped SNPs comprising the ETV5-KNG1-ADIPOQ
gene region in the mothers (19) and of 1148 SNPs in the off-
spring. To infer high-quality haplotypes, we specified 200
rounds of Markov sampling considering 500 haplotype states
when updating each individual.
Additional SNPs were genotyped using TaqMan allelic dis-
crimination (Applied Biosystems, Foster City, CA, USA), in-
cluding ADIPOQ missense SNPs G48D (ss469105329), I164T
(ss469105330) and R221S (ss469105331), and MetaboChip
ETV5 SNP rs117016164 (chr3:187 239 040, hg18). Primer
sequences are provided in Supplementary Material,
468 Human Molecular Genetics, 2012, Vol. 21, No. 2
Table S4. The two KNG1-ADIPOQ SNPs rs119243940 and
rs864265 were previously genotyped (19). Success rates
were .95% and all SNP genotypes were consistent with
Hardy–Weinberg equilibrium (P . 0.05). The non-missing
TaqMan genotypes of rs117016164 had 99.8% concordance
with the original MetaboChip genotypes. Bioinformatic anno-
tations were assigned to missense variants in the adiponectin
protein (Uniprot ID: Q15848) using PolyPhen (version 2)
(39) and SIFT (40), each using default parameters.
Sequencing
We sequenced the two translated exons of ADIPOQ in 47 off-
spring samples by PCR amplification and Sanger sequencing.
We chose all samples with adiponectin residuals .2.5 stand-
ard deviations above or below the population mean. Primer
sequences were previously published (21). Sequencing was
performed by the UNC-CH Genome Analysis Facility on a
3730xl DNA Analyzer (Applied Biosystems).
Statistical analyses
Adiponectin levels were natural log-transformed to approxi-
mate normality and SNPs were tested for association using
multivariable linear regression models in PLINK. We
assumed an additive mode of inheritance reporting b coeffi-
cients representing the estimated change in mean transformed
trait value due to each additional copy of the minor allele. In
the offspring, 1 member of each of 5 twin pairs were removed
and 79 additional samples were excluded because they lacked
non-pregnant measures of BMI in 2005. The final sample sets
consisted of 1695 non-sibling offspring and 1764 mothers with
complete sets of outcomes and covariates. Sex and BMI cov-
ariates were significantly associated (P , 0.05) with plasma
adiponectin level in the offspring (Supplementary Material,
Table S5). In the mothers, age, median-centered age2, house-
hold assets, natural log-transformed household income and
menopausal status during the 2005 survey were included as
covariates, as previously described (19). For combined ana-
lysis, age, mean-centered age2, household assets, natural log-
transformed household income and BMI during the 2005
survey were used as covariates. Combined analysis of selected
SNPs in the offspring and mothers together was performed in
SAS version 9.3 (SAS, Inc., Cary, NC, USA) using a general
linear mixed model that accounted for the relatedness between
mother–child pairs. Conditional analyses of directly geno-
typed SNPs in the offspring and mothers were performed in
SAS using linear regression. Conditional analyses of
imputed SNPs in the mothers adjusting for R221S were per-
formed using MACH2QTL (38). Haplotype association ana-
lyses in the offspring and mothers were performed in SAS.
All conditional and haplotype analyses used the corresponding
outcome and covariates from the main association analyses.
To capture population substructure in the offspring, we con-
structed 10 principal components (PCs) using the software
EIGENSOFT (41,42). We first identified a set of 40 239 inde-
pendent MetaboChip SNPs (estimated r2 ,0.001 between all
pairs of SNPs within 1 Mb windows) with observed MAF
.0.05. PCs were then constructed in 1670 CHLNS offspring
who had pair-wise identity-by-descent (p̂) ,0.1 with all
other samples, as estimated using PLINK. The remaining
104 offspring who had p̂ ≥ 0.1 with any other sample(s)
were then projected onto these PCs. Supplementary Material,
Figure S1 shows the first two PCs in all 1774 offspring
samples. We also performed a complementary analysis of
global ancestry in these samples (Supplementary Material,
Fig. S2) by re-generating PCs using a subset of 24 033 SNPs
shared with 165 CEU, 84 CHB, 86 JPT and 167 YRI
HapMap Phase III samples (genotypes available at ftp://ftp.
ncbi.nlm.nih.gov/hapmap/genotypes/hapmap3/plink_format/
draft_2/). The construction of PCs in the CLHNS mothers has
been described previously (43). No PCs were associated with
adiponectin level in either the offspring (Supplementary
Material, Table S5) or mothers (19).
Quantification of adiponectin level
Adiponectin level in plasma was originally measured in the
offspring and mothers with a commercially available ELISA
kit (R&D Systems, Minneapolis, MN, USA, #DY1065) con-
sisting of two monoclonal antibodies that recognize epitopes
within amino acids 104–244. Selected offspring samples
(n ¼ 40) re-measured by western blot included 20 R221S car-
riers and 20 sex- and BMI-matched non-carriers. The distribu-
tions of adiponectin and BMI were comparable between these
two subsets and the respective groups from which they were
drawn (data not shown). Plasma proteins were resolved by
polyacrylamide gel electrophoresis and transferred to polyvi-
nylidene difluoride membranes (Invitrogen, Carlsbad, CA,
USA). Duplicate membranes were separately probed with
rabbit polyclonal antisera generated by peptide antigens
DQETTTQGPGV (44) and DGRDGTPGEKGEKGD (Sigma,
St Louis, MO, USA), corresponding to amino acids 17–27
and 56–70, respectively. Alexa Fluor 680-conjugated goat
anti-rabbit IgG was then used as a secondary antibody (Invi-
trogen). Proteins were detected using an Odyssey imaging
system (LI-COR, Lincoln, NE, USA) and the adiponectin
bands (30 kDa) were quantified by densitometry using the
LI-COR software. The adiponectin standards used for each
assay did not allow direct comparison of the original and alter-
native measurements. Thus, all densitometry readings using a
given antibody were natural log-transformed and zero-
centered on the mean value of R221S non-carriers from that
group.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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